Most Claims Survive In Royalty Spat Over HPV Drug

By Anne Urda (May 26, 2009, 12:00 AM EDT) -- A Delaware judge has let the majority of claims stand in a breach of contract suit brought against MedImmune Inc. and Glaxo Group Ltd. over human papillomavirus vaccine Cervarix, but has dismissed claims of unjust enrichment and unfair competition, among others....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!